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Background: Malignant breast neoplasms are among the most frequent forms of cancer in the Western world.
Conventional treatment of breast cancer may include surgery, hormonal therapy, chemotherapy, radiation and/or
immunotherapy, all of which are often accompanied by severe side effects. Complementary and alternative medicine
(CAM) treatments have been shown to be effective in alleviating those symptoms. Furthermore, with patient survival
rates increasing, oncologists, psychologists and other therapists have to become more sensitive to the needs of cancer
survivors that go beyond than the mere alleviation of symptoms. Many CAM methods are geared to treat the patient
in a holistic manner and thus are also concerned with the patient’s psychological and spiritual needs.
Discussion: The use of certain CAM methods may become problematic when, as frequently occurs, patients use them
indiscriminately and without informing their oncologists. Herbal medicines and dietary supplements, especially, may
interfere with primary cancer treatments or have other detrimental effects. Thus, expertise in this highly specialized field
of integrative medicine should be available to patients so that they can be advised about the benefits and negative
effects of such preparations and practices.
Being a beneficial combination of conventional and CAM care, integrative oncology makes possible the holistic
approach to cancer care. The concept of integrative oncology for breast cancer is jointly practiced by the Department
of Internal and Integrative Medicine, Kliniken Essen-Mitte, academic teaching hospital of the University of Duisburg-
Essen, and the Breast Center at Kliniken Essen-Mitte in Germany. This model is introduced here; its scope is reviewed,
and its possible implications for the practice of integrative medicine are discussed.
Summary: Evidence-based integrative care is crucial to the field of oncology in establishing state-of-the-art care for
breast cancer patients.
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In 2008 alone, about half of a million women worldwide
died from breast cancer, one of the most frequent forms
of invasive cancer in women (International Agency for
Research on cancer, 2008). In recent years, state-of-the-
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The definition of IM in general and integrative oncology
(IO) in particular, as well as the use of their treatment
modalities, depends on the country and/or culture
within which they are practiced [1,2]. Both IM and IO
combine conventional with other medical approaches
that have been shown to be safe and effective [3] (see
Figure 1). Phrases such as “holistic”, “complementary”,
or “alternative” refer to the methods advocated by “other
medical approaches”, which include the multitude of di-
verse medical and health care systems, practices, and
products not generally considered part of conventional
medicine. The Arbeitsgemeinschaft Gynäkologische
Onkologie e.v. (AGO), which establishes yearly guidelines
for the treatment of breast cancer in Germany, definesLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Components of Integrative Oncology.
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“CAM, [. . .] comprises both alternative therapies that
are used instead of conventional, optimally scientifically
based medicine, and complementary methods that are
used in addition to conventional methods with proven
efficacy. Conventional clinicians tend to approve of a
complementary approach more readily than one of the
other options. However, if complementary approaches
are administered simultaneously with conventional ther-
apies, there is always the risk that they will interfere with
the standard treatment, e.g., in the form of drug interac-
tions with partially incalculable outcomes.” Integrative
oncology combines the best practices of conventional
and complementary oncological therapy, uniting them
into one, holistic concept. With the awareness that the
two therapeutic methods may occasionally interfere with
each other, the best solution is aimed-at.
The Concerted Action for Complementary and Alter-
native Medicine Assessment in the Cancer Field (CAM-
Cancer) project divides the CAM approaches into the
following categories (www.cam-cancer.org):
 alternative medical systems (e.g., homeopathy,
traditional Chinese medicine),
 biologically based practices (e.g., herbs, vitamins,
food),
 energy medicine (e.g., Reiki),
 mind-body medicine, (e.g., meditation, autogenic
therapy, progressive muscle relaxation), and
 manipulative and body-based practices
(e.g., massage).
In 1998, the National Center for Complementary and
Alternative Medicine (NCCAM) was established as part
of the National Institutes of Health (NIH) in the United
States. Allotted over 120 million dollars for CAM and
Mind-body medicine (MBM) research in 2008 alone, it
is the world's leading research facility for CAM (www.
nccam.nih.gov). CAM methods are now widespread and
are even included in the curricula of Western univer-
sities and institutions [4], including such prestigious
ones as Stanford University Medical School, the Harvard
Medical School, and the Memorial Sloan-KetteringCancer Center in New York, which has an Integrative
Medicine Service [5].
The field of application of IO
An important feature of IM is that it actively involves
patients in their own treatment, thus encouraging them
to take responsibility for maintaining their own health.
There are at least two outstanding reasons for integrat-
ing CAM into cancer care. First, patients with cancer
often experience multiple symptoms not only from the
cancer but also from its treatment [6]. Conventional
cancer therapies such as surgery, chemotherapy, im-
munotherapy and/or radiation are generally life-prolong-
ing, but they may also be accompanied by serious side
effects such as pain, nausea, fatigue, sleep disturbances,
oral and/or gastrointestinal ulceration and inflammation,
and manifest psychological disorders [3]. As a rule these
side effects are concomitant with the primary cancer
therapy, beginning with the first treatments, and are not
satisfactorily alleviated by conventional means. Although
they may vary in type and severity over time, they defin-
itely restrict the physical, psychological, and social func-
tions of the affected patients.
Preliminary findings indicate that supportive CAM
methods may be of value from the time a patient
receives the diagnosis of cancer on to the time of their
rehabilitation and recovery [5]. Instead of expecting to
cure their disease, patients learn to deal with it, using
CAM to strengthen their immune system, relieve pain,
and manage the side effects from the disease or its treat-
ment, often working with a supportive practitioner [7].
In particular, the fatigue and nausea caused by primary
cancer treatment may be alleviated, and recovery from
chemotherapy may be hastened [8-10]. In addition, acu-
puncture, mind-body techniques, and massage may help
relieve side effects and improve patients’ physical and
emotional well-being. At present, about one in three
breast cancer patients discontinues her hormone treat-
ments against medical advice; in such cases CAM inter-
ventions can improve compliance by reducing hot
flashes or joint pain [11-13].
A special advantage of CAM interventions is that they
are particularly well suited to treat patients in a holistic
manner, including dealing with their psychological and
spiritual needs [14]. Holistic approaches, which are often
individualized, focus on patient orientation, the patient–
doctor or –therapist relationship, and on understanding
the patient’s perspective by means of multimodal con-
cepts. Since patient survival rates have increased, oncol-
ogists, psychologists, and other therapists have to
become more sensitive to patient needs that go beyond
the mere alleviation of symptoms.
Not surprisingly, about 40% of cancer survivors use a
CAM method, and 18% use multiple CAM therapies
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2007). Among women with breast cancer, the rate of
CAM use is even up to 75% [15]. The most frequently
used CAM therapies among cancer survivors are herbal
and other natural products (the National Health Inter-
view Survey, NHIS, 2002 and 2007). Patients are likely
to be motivated to use CAM treatments by the benefits
they perceive to result from CAM, a desire to feel more
in control of their health, or a strong belief in CAM
(www.cam-cancer.org).
Unfortunately, the majority of patients use CAM
methods indiscriminately and without informing their
oncologists [1], exposing themselves to possible detri-
mental effects. These are due especially to a CAM treat-
ment interacting with their chemotherapy or endocrine
treatment. Medical professionals repeatedly criticize that
many CAM methods are poorly supported by scientific
evidence [16]. Therefore, expertise in this field of IM is
needed so that patients can be advised about the benefits
and negative effects of such CAM methods and prepara-
tions. This article introduces a German expert-based
model for IO that combines mainstream medicine and
CAM for the care of breast cancer patients.
IM in Germany
In 2004, the first German Chair for Complementary and
Integrative Medicine was established at the University of
Duisburg-Essen (chair held by GJD). Unlike in the Uni-
ted States, research funding for CAM research in Europe
is very limited. In addition the clinical practice of CAM
in Europe is based more on patient request. In the
meantime, a number of German university departments
are focusing on CAM research thanks to third-party
funds. In a cross-sectional study of medical schools in
German-speaking countries, the majority (40%) of deci-
sion makers had a positive opinion of CAM and were in
favor of integrating CAM into medical school curricula,
especially in research and education [17]. However, only
a small percentage of institutions and hospitals have ac-
tually integrated CAM methods into their programs.
This is not in line with the prevalence of usage of CAM
in the population.
The use of CAM in Western countries has increased
steadily over the past decades. Whereas several surveys
on the use of different CAM therapies and on predic-
tors of CAM usage have been carried out in the USA,
little is known about the use of CAM in Europe [1].
According to a European survey on CAM use in cancer
patients, the most commonly used CAM therapies were
herbal medicines and remedies, homeopathy, vitamins/
minerals, medicinal teas, spiritual therapies, and relax-
ation techniques. Predictors for CAM use are a young
age, female sex, and a higher level of education [1]. The
most frequently used methods in children with cancerwere homeopathy, dietary supplements, and anthropo-
sophic medicine (AM), including mistletoe therapy [18].
However, the data on CAM use in the care of German
cancer patients is still insufficient, there being more spe-
cific data on CAM use in general. In the year 2000, the
Allensbach Institute for Public Opinion Polling esti-
mated from 2111 face-to-face interviews that 50% of the
German population had personally used at least one
CAM method at some time [19]. Two years later, 73% of
the German population used CAM [19]. Popular meth-
ods included naturopathy (48%), autogenic training
(29%), and meditation (21%), as well as acupuncture
(25%) and acupressure (12%). The rates are highly
dependent on the patient’s symptoms: Patients present-
ing with headache most frequently used acupuncture
(58.3%), massage (46.1%), and relaxation techniques
(42.4%) [20]. General medicine practices most commonly
employ neural therapy, phytotherapy, and acupuncture
(ca. 65%, 53%, and 38%) [21]. Older German adults most
frequently used acupuncture/traditional Chinese medi-
cine (21%), homeopathy (21%), movement therapies/
physical exercises (19%), osteopathy/chiropractic (12%),
herbs/phytotherapy (7%), diets/specific food recommen-
dations (6%), and foot reflexology (5%) [22]. According
to a cross-sectional survey on consecutive patients visit-
ing the Comprehensive Cancer Center in Munich,
Germany, the most common CAM treatments were diet
(40%), physical exercise (28%), and dietary supplements
(28%) [23]. While 52% used at least one CAM method,
only 34% described themselves as well informed about
CAM. Interestingly, there are indications that involve-
ment in self-support groups and leisure activities are
associated with CAM use in breast cancer patients [24].
It should be noted that the differences in percentages
may not be as specific as they might seem at first glance.
In a survey of the Robert-Koch Institute on CAM use in
Germany the authors remarked that terms such as alter-
native, complementary, or naturopathic medicine are
highly unspecific, and divergent survey outcomes may
be the result of differing individual views on what these
terms exactly include [25].
Nevertheless, the relevance of specific CAM interven-
tions may vary among different countries, depending on
the socio-cultural background, availability of approaches,
financial resources, and specific individual preferences.
German-speaking countries have the highest prevalence
of CAM use among the European countries [26]. This
may be explained by the fact that homeopathy, AM, and
naturopathy have their origins in the German-speaking
countries. Thus, many home remedies and self-
medication practices are rooted in the health care
approaches of these countries [26].
AM was introduced by Steiner and Wegman in the
early 20th century. Homeopathic remedies, whole plant
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massage, and biographical counseling are examples of
AM methods. The AM treatment with the highest rele-
vance for cancer patients may be the use of mistletoe.
Homeopathy is an alternative medical system from
Germany, introduced by the German physician Samuel
F.S. Hahnemann. It is based on the idea that a sub-
stance that causes symptoms of a certain disease in
healthy individuals can be used to treat patients with
that disease. Kneipp medicine, conceived by Sebastian
Kneipp, consists of naturopathic treatments such as
hydrotherapy, nutritional therapy, and phytotherapy.
Many other medical systems may also be applied in IO,
and the methods of these patient-centered holistic
approaches overlap with one another. Many single
treatment options of these CAM systems are safe, some
have a good evidence base and are thus also adequate
for integrative oncological care.
An IM treatment method with relatively good evi-
dence supporting its efficacy is MBM that encompasses
a variety of therapeutic techniques (e.g. psychological
education, nutritional counseling, physiological exercise,
and elicitation of the relaxation response and/or mind-
fulness) to enhance the patient’s natural capacity for
mental and physical self-healing. MBM uses a holistic
approach to health and healing that is supported by re-
search on stress physiology/psychology, on psycho-
neuro-(endocrino-)immunology, and on the social and
spiritual aspects of health. Several reviews of the use of
MBM underline its efficacy in improving quality of life,
immune function, the quality of sleep, and some psycho-
logical parameters in cancer patients [27-30]. Even a
short-term MBM intervention of eight weeks can induce
significant epigenetic changes, which may relate to long-
term physiological effects [31]. Important contributions
to MBM were made during the 1970s and 80s by prom-
inent clinicians like Benson at Harvard Medical School
[32,33] and Jon Kabat-Zinn at the University of Massa-
chusetts Medical Center [34,35] and their coworkers.
Benson focused on cognitive restructuring, relaxation
techniques, exercise, diet, and social support, while
Kabat-Zinn’s program emphasizes the role of meditation
and the development of mindfulness in daily life. Breast
cancer patients who participated in a mindfulness-based
stress reduction (MBSR) program experienced a de-
crease in stress, depression, and other symptoms and
were better able to cope with their illnesses [36].
An example of IO in Germany - the practice at Kliniken
Essen-Mitte
Set-up and clinical services
Since the beginning of 2010, the Breast Center (under
the direction of PD Dr. Kümmel) and the Department
of Internal and Integrative Medicine, Kliniken Essen-Mitte, academic teaching hospital of the University of
Duisburg-Essen (Prof. Dr. Dobos), have been cooperat-
ing in patient care at the Kliniken Essen-Mitte. Each of
the breast cancer patients treated there receives an indi-
vidualized treatment plan based on the current literature
and guidelines. The IO team, consisting of physicians
and CAM therapists, reviews current international liter-
ature, guidelines, and health technology assessments
relevant to every single breast cancer patient. Individual
IO treatment plans are formulated based on detailed
analyses of a patient’s case and the results of their indi-
vidual tumor conferences, all contained in a database, as
well as on SenoExpert.
SenoExpert was introduced as a special database for
breast cancer patients to aid in meeting the current
scientific standards for high-quality patient care (see
Figure 2). The database is continually up-dated by
scientists, physicians, and MBM instructors who regu-
larly review the medical literature and screen it for new
guidelines. In addition, online conferences are held at
regular intervals in which experts discuss anonymized
breast cancer cases. The aim of these undertakings is
to make the current guidelines and scientific evidence
readily available to physicians responsible for the rou-
tine care of the patients.
The average duration of hospitalization is 3–4 days.
Subsequently either the patient is treated in the out-
patient clinic of the breast center, or the referring phys-
ician is sent detailed recommendations for the patient’s
follow-up treatment.
In addition to receiving conventional treatment (see
Figure 3), every patient in our department is routinely
offered a consultation with a complementary and inte-
grative medicine (CIM) physician and a MBM in-
structor. The CIM members of the IO team are trained
in naturopathy, nutrition, sports pedagogic, and psy-
cho-oncology, and they educate, and support patients
in coping with their diseases and treatments. Each
MBM consultation is based on the patient’s answers to
a standardized questionnaire that inquires about the
patient’s knowledge of her own diagnosis and its ther-
apy, her previous experience with CIM and/or CAM
methods, and her quality of life, psychological factors,
and lifestyle. The questionnaire combines validated
tools (Hamilton anxiety and depression scale, HADS;
the EORTC QLC-C30 and EORTC QLC-BR23 of the
European Organization for Research and Treatment of
Cancer; the Brief Fatigue Inventory, BFI; and others)
with items developed by one of our focus groups.
In 2010 and 2011, a total of 726 patients with the pri-
mary diagnosis of breast cancer were treated at the
Department of Senology of the University of Duisburg-
Essen. Beginning in October 2010, around 200 patients
were additionally seen by CIM physicians who became
Figure 2 The concept of SenoExpert as an evidence-based database.
Figure 3 Components of Integrative Oncology at the Breast Center at the Kliniken Essen-Mitte, Germany.
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patients treated with CIM is steadily growing. Most of
these patients presented with side effects from chemo-
therapy and/or endocrine treatment or the initial phases
of anxiety and depression. The most frequent side effects
reported were: gastrointestinal disorders, polyneurop-
athy, xerostomia, a fatigue syndrome during chemother-
apy, joint pain and hot flashes (secondary to aromatase
inhibitors or tamoxifen), depression and pain, and post-
surgical hematoma or venous congestion. The CIM
treatment for painful hematoma and venous congestion
is leech therapy. According to our initial analysis, (ear,
body) acupuncture reduced the side effects of endocrine
therapy in 70% of our patients. Phytotherapy also helps
to reduce the side effects of standard cancer treatments.
Neuraltherapy, guasha massage, and cupping massage
are employed to alleviate symptoms such as pain in scars
or general post-surgical pain. In addition, physical exer-
cisies, yoga, and training in mindfulness, relaxation, and
nutrition are utilized to enhance the patient’s capacity
for mental and physical self-healing. Mistletoe (Viscum
album) and other treatments that have been shown to
be efficacious, safe, and effective may also be applied.
Thus, these integrative treatments are mostly applied to
alleviate side effects, treat acute symptoms, and support
patients in coping with their illness and in altering their
lifestyle.
Additionally, the Department of Complementary and
Integrative Medicine offers a day clinic program for on-
cology patients that is based on the principles of MBM.
So far about 1500 patients have been treated within this
setting. Our especially trained MBM instructors teach
classical mindfulness concepts and offer modified
mindfulness-based therapy classes (11 weeks, 6 hrs per
meeting) that integrate nutritional seminars (lectures in
a teaching kitchen), exercise training (walking, yoga, or
qigong), and group support and self-care strategies (e.g.
cupping massage, hydrotherapy). In addition, physicians
specialized in naturopathy inform the patients about
neuropathic treatments, and the nursing department
provides information about methods such as wraps and
cupping. The day clinic is mainly focused on consolidat-
ing techniques the patients have learned, enhancing
mindfulness in daily-life, promoting self-care and self-
knowledge, coping with the individual illnesses, and ad-
vising patients about lifestyle.
At present, several trials are being carried out to evalu-
ate the ambulatory medical service at the Breast Center
and the multimodal day clinic at our department. In
addition, 6 and 12 months after completing their ther-
apy, patients who have been treated at our clinic and
consent to follow up are sent standardized question-
naires dealing with their QoL, psychological symptoms,
dietary habits, and activities.Discussion
With CIM becoming very popular among cancer
patients worldwide [14,17,37,38], we have established a
breast cancer center according to the concept of IO in
Germany.
One of the leading international centers in integrative
oncology is the Memorial Sloan-Kettering Cancer Center
in New York with its Integrative Medicine Service being
the role model of our center [37]. This service is a hori-
zontal academic unit that interacts with all other depart-
ments within the institution. A wide range of evidence-
based complementary therapies including acupuncture,
massage, music therapy, meditation, nutrition, counsel-
ling, and physical exercise are applied to optimize the
patient’s overall treatment management [37].
The University of Texas M D Anderson Cancer
Center’s Integrative Medicine Clinic is another world-
leading cancer center with a long tradition in
comprehensive cancer care [38]. Teams of experts
from different disciplines collaborate on finding the
best treatment plans for patients with various cancer
diagnoses. An evaluation report revealed that most of
their patients had advanced disease. In the authors’
view, CIM therapies came into play when the primary
treatments had failed and the diseases had progressed,
at which point the patients’ desire to try alternatives
in treatment became more pronounced [38].
The concept of CIM is also successfully practiced in
the Middle East. In 2008, an Integrative oncology pro-
gram within the Clalit Health Organization’s oncology
service at the Lin Medical Center, Haifa, Israel was
established [39]. Its focus lies on supportive care during
chemotherapy and advanced cancer using diet and
supplements, herbal medicine, mind-body and touch
therapies, acupuncture, AM, homeopathy and spiritual
care [39].
In general, traditional medicine systems are very pa-
tient-oriented. By considering the traditional medicine
backgrounds of patients, practitioners can engage in a
deeper and more beneficial dialogue with their patients
[14,39,40]. The need for a sensitive cross-cultural ap-
proach under consideration of social, cultural, and spirit-
ual elements is particularly important in countries where
patients’ beliefs derived from their cultural background
and explanatory models of conventional medicine are
difficult to reconcile [14]. Knowledge of the cross-
cultural perspectives and co-existing health belief models
of other cultures is of great value in treating the patients
of these cultures.
In the Middle East, a collaboration of researchers of
various countries met via the Middle East Cancer Con-
sortium (MECC) to design an integrative oncology pro-
gram based on a three-stage process [39,40]: After an
initial historical and ethno-botanical search in Middle
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for CAM studies in cancer care in the Middle East was
conducted, and finally, potentially useful herbs were
selected for additional clinical research for this region.
The focus lied in exploration of the potential role of
Middle Eastern plants in cancer care by comparing these
historical resources with contemporary scientific litera-
ture [41].
Unlike the in United States, funding for CAM research
and its clinical application in Germany is very limited.
While acceptance of CAM is generally growing and the
decision makers of medical schools in German-speaking
countries are positively inclined to integrate CAM into
school curricula, only a small percentage of clinics and
institutes have integrated CAM into their practices to
date [17]. Compared with the international centers, our
center in Essen is relatively small. However, unlike in
other institutions, CIM therapies are directly implemen-
ted as a part of routine care in our breast center. CIM
therapists and conventional caregivers work hand-in-
hand.
Future challenges include extending the range of CIM
therapies offered in our breast center and establishing
further CIM practice in other oncological departments.
All in all, the IO methods we practice are restricted to
scientifically evaluated interventions. The majority of
our patients appreciate the concept of IO, the treat-
ments of which are partly covered by German insurance
companies.
Conclusion
Our IO model is well accepted by patients, and we have
observed substantial benefits to them as a result of our
treatments. However, further scientific evaluation of the
specific add-on efficacy and cost-effectiveness of CAM
treatments is urgently needed. Further research is also
required to establish IO as an integral component of
cancer treatment.
In our opinion, integrative care is crucial to the field
of oncology and to establishing state-of-the-art breast
cancer care. The potential of IM and IO lies in prevent-
ing illness and enhancing self-healing abilities, as well as
in supporting mainstream treatment in order to speed
up recovery processes, minimize side effects, and
thereby reduce health-care costs.
Summary
After many years of clinical and experimental practice in
IM, we have achieved a great deal and have received rec-
ognition from patients and medical professionals. How-
ever, CAM treatments still need to be evaluated by more
rigorous scientific methods. Three major factors must be
considered in choosing a best treatment option: 1) the
level of evidence supporting the efficacy of a treatment,2) the cost of therapy, and 3) its safety, i.e., the existence
of potential side effects. Western physicians and thera-
pists are educated to question therapeutic strategies that
are not based on rigorous evidence.
In our opinion the main challenge for IO at present is
to analyze the complexities of the dynamic, multimodal,
and individualized treatment strategies in integrative
cancer care. Instead of concentrating solely on various
trials of single treatment options, holistic strategies
should be evaluated. However, scientific methods
designed with settings appropriate for pharmaceutical
trials are of limited scope for many IO treatment mo-
dalities. Randomized controlled trials, the scientific
gold-standard, may be insufficient to address relevant
questions about the outcomes of whole system strat-
egies, since CAM therapies do not focus on isolated
pathological processes, but rather on the whole patient
with all of his or her complexities. CAM therapy sys-
tems are often based on long traditions and experience
in patient care, while rigorous scientific evidence is
often lacking. Substantial efforts are made to emerge
clinical and laboratory investigations also for comple-
mentary therapies. In developing conventional drug
therapies, laboratory investigations are carried out first,
then phase I-III trials are conducted and finally clinical
experience is gained. The order of clinical experience
and systematic evaluation is reversed for CAM therap-
ies on the one hand and conventional drug therapies
on the other [42].
In most RCTs considerable efforts are made to avoid
systematic bias. These efforts can cause a gap between
the conditions of the traditional RCTs for the proof of
efficacy and real-world healthcare. Well-designed obser-
vational studies in real-world conditions might enhance
our understanding of the processes and provide better
understanding of patient preferences and the underlying
mechanisms in action. Although observational studies
do not allow us to make conclusions about the cause of
the efficacy of an intervention, they do help us gain
knowledge about particular types of treatments and how
they can be combined in standard care. We can observe
whether patients get better overall and whether side
effects occur. Observational studies and especially those
that have a control group could provide useful data in
the field of comparative effectiveness research. Syste-
matic CIM assessments should utilize a broad array of
diverse high-quality research methods and include ran-
domized and non-randomized studies, cross-sectional
studies, pragmatic trials, comparative effectiveness re-
search, qualitative studies, case series, and socioeco-
nomic analyses. But what we do need first and foremost
is more systematic data on the safety and adverse side
effects of CAM options. On a practical perspective, the
experience shows that patients may not only use CAM
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mation will help physicians broaden their radius of op-
eration and meet patients’ requests at once.
At the same time, we should consider that other cri-
teria might apply for chronically ill patients. Many of the
growing number of cancer survivors may profit from
CAM options with low toxicity as an adjunct to their
conventional treatments. Unlike researchers, patients are
often not primarily interested in general physiological
outcomes; rather, they want to regain control over their
lives and enhance the quality of their lives. We hope that
further trials investigating CAM modalities will under-
line the benefits we see in daily practice.
Future challenges lie in promoting the concept of IO
in medical school curricula and in continuing education
courses for oncologists, therapists, nurses, and family
physicians. Only then will referring physicians, thera-
pists, and nurses routinely recognize the patient’s need
for holistic support.
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